228 related articles for article (PubMed ID: 36126315)
1. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
[No Abstract] [Full Text] [Related]
2. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
[TBL] [Abstract][Full Text] [Related]
3. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
[No Abstract] [Full Text] [Related]
5. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis.
Ridner SH; Dietrich MS; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder SM; Wagner J; Abramson V; Moore A; Shah C
Ann Surg Oncol; 2019 Oct; 26(10):3250-3259. PubMed ID: 31054038
[TBL] [Abstract][Full Text] [Related]
6. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
7. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
[TBL] [Abstract][Full Text] [Related]
8. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
9. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
[TBL] [Abstract][Full Text] [Related]
10. Current Diagnostic Tools for Breast Cancer-Related Lymphedema.
Shah C; Asha W; Vicini F
Curr Oncol Rep; 2023 Mar; 25(3):151-154. PubMed ID: 36696076
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
[TBL] [Abstract][Full Text] [Related]
13. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
[TBL] [Abstract][Full Text] [Related]
14. Does Manual Lymphatic Drainage Add Value in Reducing Suprafascial Fluid Accumulation and Skin Elasticity in Patients With Breast Cancer-Related Lymphedema?
De Vrieze T; Gebruers N; Nevelsteen I; Thomis S; De Groef A; Tjalma WAA; Belgrado JP; Vandermeeren L; Monten C; Hanssens M; Asnong A; Dams L; Van der Gucht E; Heroes AK; Devoogdt N
Phys Ther; 2022 Dec; 102(12):. PubMed ID: 36209432
[TBL] [Abstract][Full Text] [Related]
15. Effect of exercise mode on physical function and quality of life in breast cancer-related lymphedema: a randomized trial.
Basha MA; Aboelnour NH; Alsharidah AS; Kamel FH
Support Care Cancer; 2022 Mar; 30(3):2101-2110. PubMed ID: 34669036
[TBL] [Abstract][Full Text] [Related]
16. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
[TBL] [Abstract][Full Text] [Related]
17. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
18. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
[TBL] [Abstract][Full Text] [Related]
19. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
